Alvotech (HAM:Z45)
€ 2.95 +0.22 (+8.06%) Market Cap: 980.09 Mil Enterprise Value: 2.20 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 48/100

Alvotech SA at Goldman Sachs Healthcare Conference Transcript

Jun 8, 2026 / 12:40 PM GMT
Release Date Price: €3.06 (-3.77%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ALVO.OQ - Alvotech SA
Alvotech SA at Goldman Sachs Healthcare Conference
Jun 08, 2026 / 12:40PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Great. Well, good morning, everyone, and thank you for joining us. My name is Matt DeLatore, and I'm a biopharma analyst here at Goldman Sachs. And we're very pleased to continue the next session this morning with Alvatech, where I'm joined by Robert Westman, Founder and Executive Chairman, and Balaji Prasad, Chief Strategy Officer.

Robert and Balaji, thank you for being here.

Thank you for hosting.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thanks for inviting.

--------------------------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot